SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022601
Filing Date
2022-11-07
Accepted
2022-11-07 16:11:48
Documents
64
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q allk-20220930.htm   iXBRL 10-Q 2627417
2 EX-31.1 allk-ex31_1.htm EX-31.1 22400
3 EX-31.2 allk-ex31_2.htm EX-31.2 22423
4 EX-32.1 allk-ex32_1.htm EX-32.1 12491
5 EX-32.2 allk-ex32_2.htm EX-32.2 12510
  Complete submission text file 0000950170-22-022601.txt   9408301

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allk-20220930_cal.xml EX-101.CAL 43535
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allk-20220930_def.xml EX-101.DEF 148888
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20220930_pre.xml EX-101.PRE 292547
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20220930_lab.xml EX-101.LAB 403617
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20220930.xsd EX-101.SCH 43486
58 EXTRACTED XBRL INSTANCE DOCUMENT allk-20220930_htm.xml XML 2112587
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38582 | Film No.: 221365541
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences